Esophageal Cancer Market Report 2024-2033 | Size, Growth, Growth Demand, Trends

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Esophageal Cancer Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $1.94 billion In 2028 At A CAGR Of 8.9%.

The esophageal cancer market size has grown rapidly in recent years. It will grow from $1.25 billion in 2023 to $1.38 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increased number of cancer, improvement in healthcare infrastructure, rise in alcohol consumption, growth in demand for preventive healthcare solutions, increase in prevalence of esophageal adenocarcinoma.

The esophageal cancer market size is expected to see strong growth in the next few years. It will grow to $1.94 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to rising prevalence of esophageal cancer, increasing public understanding of healthcare, improvements in healthcare infrastructure, chronic consumption of smoking and alcohol, increasing prevalence of esophageal adenocarcinoma. Major trends in the forecast period include technological advancements in treatment options, increased investment in research and development, increasing utilization of precision medicine, development of targeted therapies, increased participation in clinical trials and collaborations between academia, pharmaceutical companies, and healthcare institutions.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=12637&type=smp

Esophageal Cancer Market Major Segments
The esophageal cancer market covered in this report is segmented -

1) By Type: Esophageal Squamous-Cell Carcinoma, Esophageal Adenocarcinoma, Other Types
2) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End Users: Hospitals, Homecare, Specialty Centers, Other End Users

Key Driver - Rising Incidence Of Esophageal Cancer Fuels Market Growth

An increase in esophageal cancer is expected to propel the esophageal cancer market growth. Esophageal cancer is a malignancy that affects the esophagus, the tube-like structure connecting the throat to the stomach. As the incidence of esophageal cancer increases, there will be a higher demand for diagnostic procedures, such as endoscopy, imaging tests, and biopsies, to detect and confirm the presence of the disease. For instance, in February 2023, according to the National Library of Medicine, a US-based medical library operated by the American government, the incidence rate of esophageal adenocarcinoma among individuals aged 40-65 is projected to rise from 2.12 per 100,000 persons in 2021 to 3.86 per 100,000 persons in 2040. This represents an 82% increase over 19 years, equivalent to a yearly growth rate of 3.2%. Therefore, the increase in esophageal cancer is expected to drive the growth of the esophageal cancer market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=12637&type=smp

Prominent Trend - Drug Approvals Propel Advancements In The Esophageal Cancer Market

New drug approval is a key trend gaining popularity in the esophageal cancer market. Major companies operating in the esophageal cancer market are focused on obtaining new drug approvals to strengthen their position and gain a competitive advantage. For instance, in May 2022, Bristol Myers Squibb, a US-based pharmaceutical company, received U.S. Food and Drug Administration (FDA) approval for its two products, including Opdivo (nivolumab) (injection for intravenous use) and Opdivo plus Yervoy (ipilimumab). Its primary therapeutic approaches are for individuals diagnosed with advanced or metastatic esophageal squamous cell carcinoma (ESCC). The authorization was granted following the Phase 3 clinical trial evaluation, which demonstrated enhanced overall survival rates among patients who received these medications.

Esophageal Cancer Market Players
Major companies operating in the esophageal cancer market report are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc, AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Servier Pharmaceuticals, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Ipsen SA, Dr. Reddy's Laboratories Ltd., Seagen Inc., Exelixis Inc., BeiGene Ltd., Clovis Oncology Inc., Aslan Pharmaceuticals Ltd.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/esophageal-cancer-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the esophageal cancer market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the esophageal cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Esophageal Cancer Market Report Structure
3. Esophageal Cancer Market Trends And Strategies
4. Esophageal Cancer Market - Macro Economic Scenario
5. Esophageal Cancer Market Size And Growth
…..
27. Esophageal Cancer Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.